UNCY logo

Unicycive Therapeutics (UNCY) Enterprise Value

Enterprise Value

$24.55 M
-$3.07 M-11.12%

11 min ago


Summary


Performance

UNCY Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherUNCYvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

UNCY Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-11.1%-5.2%-5.2%
1 m1 month-14.3%-6.8%-6.8%
3 m3 months-43.2%-24.9%-24.9%
6 m6 months+402.3%+69.8%+54.4%
ytdytd-52.3%-32.5%-32.5%
1 y1 year-40.3%+12.1%-62.5%
5 y5 years---

UNCY Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-25.2%$21 M+14.8%
3 m3-month$54 M-54.6%$21 M+14.8%
6 m6-month$54 M-54.6%-$8 M+402.3%
1 y1-year$54 M-54.6%-$32 M+175.7%
3 y3-year$54 M-54.6%-$32 M+175.7%
5 y5-year$89 M-72.4%-$32 M+175.7%
alltimeall time$89 M-72.4%-$32 M+175.7%

Unicycive Therapeutics Enterprise Value History

DateValue
2025
$24.55 M(-52.3%)
2024
$51.50 M(+137.8%)
DateValue
2023
$21.65 M(+176.9%)
2022
$7.82 M(-46.6%)
2021
$14.65 M

FAQ

  • What is Unicycive Therapeutics enterprise value?
  • What is the all time high enterprise value for Unicycive Therapeutics?
  • What is UNCY enterprise value year-to-date change?
  • What is Unicycive Therapeutics enterprise value year-on-year change?

What is Unicycive Therapeutics enterprise value?

The current enterprise value of UNCY is $24.55 M

What is the all time high enterprise value for Unicycive Therapeutics?

Unicycive Therapeutics all-time high enterprise value is $88.93 M

What is UNCY enterprise value year-to-date change?

Unicycive Therapeutics enterprise value has changed by -$26.95 M (-52.32%) since the beginning of the year

What is Unicycive Therapeutics enterprise value year-on-year change?

Over the past year, UNCY enterprise value has changed by -$16.60 M (-40.34%)